195 related articles for article (PubMed ID: 28336941)
1. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.
Dong JY; Ning JX; Li K; Liu C; Wang XX; Li RH; Yue LL; Huang YY; Liu SH
Sci Rep; 2017 Mar; 7(1):342. PubMed ID: 28336941
[TBL] [Abstract][Full Text] [Related]
2. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.
Tiwari P; Pandey V; Gangopadhyay AN; Sharma SP; Gupta DK
Oral Maxillofac Surg; 2016 Mar; 20(1):73-7. PubMed ID: 26481918
[TBL] [Abstract][Full Text] [Related]
3. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
4. Large Doses of Propranolol for the Treatment of Infantile Cephalic and Facial Hemangiomas: A Clinical Report of 38 Cases.
Jianguo K; Xichun W; Mingkun Z; Qiaoling C; Wenjin L
J Clin Pediatr Dent; 2015; 39(3):268-71. PubMed ID: 26208073
[TBL] [Abstract][Full Text] [Related]
5. Infantile Hemangiomas in the Head and Neck Region.
Adams DM; Ricci KW
Otolaryngol Clin North Am; 2018 Feb; 51(1):77-87. PubMed ID: 29217069
[TBL] [Abstract][Full Text] [Related]
6. Sequelae following infantile haemangiomas treated with propranolol.
Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
[TBL] [Abstract][Full Text] [Related]
7. Propranolol for infantile haemangioma: striking effect in the first weeks.
Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.
Ahogo CK; Ezzedine K; Prey S; Colona V; Diallo A; Boralevi F; Taïeb A; Léauté-Labrèze C
Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995
[TBL] [Abstract][Full Text] [Related]
9. Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
Lv MM; Fan XD; Su LX
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):574-8. PubMed ID: 22326207
[TBL] [Abstract][Full Text] [Related]
10. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
[TBL] [Abstract][Full Text] [Related]
11. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies.
Lou Y; Peng WJ; Cao Y; Cao DS; Xie J; Li HH
Br J Clin Pharmacol; 2014 Jul; 78(1):44-57. PubMed ID: 24033819
[TBL] [Abstract][Full Text] [Related]
13. Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age.
Léauté-Labrèze C; Dumas de la Roque E; Nacka F; Abouelfath A; Grenier N; Rebola M; Ezzedine K; Moore N
Br J Dermatol; 2013 Jul; 169(1):181-3. PubMed ID: 23301692
[No Abstract] [Full Text] [Related]
14. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
15. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas.
Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R
Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620
[TBL] [Abstract][Full Text] [Related]
16. Propranolol-resistant infantile haemangiomas.
Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
[TBL] [Abstract][Full Text] [Related]
17. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
Phillips RJ; Penington AJ; Bekhor PS; Crock CM
J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
[TBL] [Abstract][Full Text] [Related]
18. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
20. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
